DiaMonTech announced today that it raised $5 million to bring its total funding to more than $20 million to date.
Berlin, Germany-based DiaMonTech develops a patented, mid-infrared technology platform designed to enable non-invasive blood glucose measurement using a pain-free laser-based detection that has ease of use comparable to the fingerprint sensor on a smartphone.
Get the full story at our sister site, Drug Delivery Business News.